Company issues cannabis recall due to lower THC content

Hexo is recalling a batch of Helio Fleur dried cannabis sold by the SQDC because of its lower THC content than indicated on the label. The dried cannabis boxes concerned are “HELIOS Fleur” and were sold between August 27th and September 6th, 2019 in a 3.5 g format. Health Canada reminds Canadians to report any health or safety complaints related to the use of cannabis products.

(Featured image by Coastal Elite via Wikimedia. CC BY-SA 2.0)

A Canadian cannabis company is issuing a cannabis recall due to lower THC content. To date, HEXO has received a complaint regarding the recalled batch.

“No reports of adverse reactions related to these products have been reported to HEXO or Health Canada,” says the Health Canada advisory.

The packaging indicates the lot number “AAA-112502”. Also, it shows the total THC quantity of 12.12%, whereas the latter should be 6.36%.

Hazard identified

Furthermore, 245 units in this lot may contain a different cannabis product with a lower THC content than the labeled THC total.

Details regarding the incorrectly packaged product are below.

Product Name

Product Size

Lot Number

THC Quantity

BAYOU Flower

3.5g

AAA-112505

THC Total: 6.36%

To date, HEXO has received one complaint related to the recalled lot. On the other hand, Health Canada has not received any complaints related to the recalled lot.

The recall involves one lot of HEXO’s dried cannabis which was sold through the Société québécoise du cannabis (SQDC). (Source)

To clarify, neither Health Canada nor HEXO has received any adverse reaction reports for the recalled cannabis product.

16,818 units of the recalled products were sold. The recalled product was sold from August 27th to September 6th, 2019.

Consumers must verify if their cannabis is affected

Above all, if you are in possession of the above product, please return it to the retailer you purchased it from. In addition, customers may contact the SQDC at 1-888-551-2161 for more information.

Health Canada would like to remind Canadians to report any health or safety complaints related to the use of this cannabis product by filling out the online complaint form. This also includes any other cannabis product.

The product has been identified as lot number 1204201 and bears the UPC code of 828939111631.

This is one of several recalls for cannabis since legalization in October 2018. But it is the first time an UP Cannabis Inc. product is affected.

Previous recalls involved Redecan based in Ontario and Bonify located in Manitoba.

Cannabis recall addresses product labeling

This was because of the packaging of the product. The THC (delta-9-tetrahydrocannabinol) content identified on the label was higher.

Also, the CBD (cannabidiol) content identified on the label was lower than the concentration present in the product.

Health Canada would like to remind Canadians to report any health or safety complaints related to the use of this cannabis product. (Source)

For lot 17-118-2042, the products packaged contained a THC value of 16.2% instead of 8.17% THC. Moreover, the CBD value is 0.05% instead of 5.91% CBD.

To clarify, type II recall refers to a situation in which the use of, or exposure to a product may cause temporary adverse health consequences. Also, the probability of serious adverse health consequences is remote.

As a conclusion, to date, Health Canada has not received any adverse reaction reports for this product sold by Aurora Cannabis Enterprises Inc.

First published in tvanouvells.ca a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Valerie Harrison is a mom of two who likes reporting about the world of finance. She learned about the value of investing at a young age upon taking over her family's textile business when she was just a teenager. Valerie's passion for writing can be traced back to working with an editorial team at her corporate job, where she spent significant time working on market analysis and stock market predictions. Her portfolio includes real estate funds, government bonds, and equities in emerging markets such as cannabis, artificial intelligence, and cryptocurrencies.

Comments are closed for this post.

Download Hemp.im

Get the latest Hempnews delivered staright to your pocket with Hemp.im!

Download Hemp.im App

Get the latest Hemp news delivered straight to your pocket with Hemp.im!

Stay in touch with us

HEMP.IM uses cookies in order to improve your experience and make further customizations to how we present our content. By continuing to use our website, you accept and give your consent to our practices as described in the following: our revised Privacy Policy, Cookie Policy, and Terms of Use.I CONSENT